Sanctuary Advisors’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$25.5M Buy
1,059,033
+45,358
+4% +$1.19M 0.12% 181
2026
Q1
$28.5M Buy
1,013,675
+59,828
+6% +$1.59M 0.15% 143
2025
Q4
$23.8M Buy
953,847
+36,705
+4% +$926K 0.13% 173
2025
Q3
$23.4M Buy
917,142
+258,885
+39% +$6.39M 0.13% 167
2025
Q2
$16M Buy
658,257
+706
+0.1% +$16.5K 0.1% 219
2025
Q1
$16.7M Sell
657,551
-24,954
-4% -$653K 0.12% 191
2024
Q4
$18.4M Sell
682,505
-89,851
-12% -$2.44M 0.12% 185
2024
Q3
$19.8M Buy
772,356
+181,435
+31% +$5.29M 0.13% 174
2024
Q2
$15M Buy
+590,921
New +$16.3M 0.11% 197

Other funds holding PFE

Sanctuary Advisors's PFE Position: Q2 2026 in Review

Sanctuary Advisors increased its Pfizer (PFE) stake by 4.5% in Q2 2026, buying an estimated $1.19M and bringing the position to 1,059,033 shares worth $25.5M. The position accounts for 0.12% of the portfolio, ranked #181.

Sanctuary Advisors first reported a position in PFE in Q2 2024 and has held it in 9 quarters since. The position peaked at $28.5M in Q1 2026. 2,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Sanctuary Advisors held 1,059,033 shares of Pfizer worth $25.5M as of Q2 2026.
  • Sanctuary Advisors bought 45,358 Pfizer shares in Q2 2026, an estimated $1.19M.
  • Pfizer made up 0.12% of Sanctuary Advisors's portfolio in Q2 2026, its #181 holding.
  • Sanctuary Advisors first reported a position in Pfizer in Q2 2024 and has held it in 9 quarters since.
  • Sanctuary Advisors's Pfizer position peaked at $28.5M in Q1 2026.
  • 2,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Sanctuary Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.